Published in

Elsevier, Multiple Sclerosis and Related Disorders, (53), p. 103012, 2021

DOI: 10.1016/j.msard.2021.103012

Links

Tools

Export citation

Search in Google Scholar

The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

Journal article published in 2021 by Johanna B. Andersen, Sifat Sharmin, Mathilde Lefort ORCID, Nils Koch-Henriksen ORCID, Finn Sellebjerg, Per Soelberg Sørensen, Claudia C. Hilt Christensen, Peter V. Rasmussen, Michael B. Jensen, Jette L. Frederiksen ORCID, Stephan Bramow ORCID, Henrik K. Mathiesen, Karen I. Schreiber, Dana Horakova, Eva K. Havrdova and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO